PRF Technologies (PRFX) Stock Overview
A specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
PRFX Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
PRF Technologies Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.86 |
| 52 Week High | US$7.95 |
| 52 Week Low | US$0.85 |
| Beta | 1.04 |
| 1 Month Change | -16.50% |
| 3 Month Change | -36.76% |
| 1 Year Change | -87.89% |
| 3 Year Change | -99.82% |
| 5 Year Change | -99.90% |
| Change since IPO | -99.90% |
Recent News & Updates
Recent updates
Shareholder Returns
| PRFX | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -11.1% | -3.4% | -1.0% |
| 1Y | -87.9% | 44.7% | 14.1% |
Return vs Industry: PRFX underperformed the US Pharmaceuticals industry which returned 43.7% over the past year.
Return vs Market: PRFX underperformed the US Market which returned 13.1% over the past year.
Price Volatility
| PRFX volatility | |
|---|---|
| PRFX Average Weekly Movement | 27.7% |
| Pharmaceuticals Industry Average Movement | 8.6% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in US Market | 15.3% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: PRFX's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: PRFX's weekly volatility (28%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 7 | Efi Cohen-Arazi | www.painreform.com |
PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company was formerly known as PainReform Ltd.
PRF Technologies Ltd. Fundamentals Summary
| PRFX fundamental statistics | |
|---|---|
| Market cap | US$2.82m |
| Earnings (TTM) | -US$5.32m |
| Revenue (TTM) | US$31.00k |
Is PRFX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PRFX income statement (TTM) | |
|---|---|
| Revenue | US$31.00k |
| Cost of Revenue | US$126.00k |
| Gross Profit | -US$95.00k |
| Other Expenses | US$5.22m |
| Earnings | -US$5.32m |
Last Reported Earnings
Jun 30, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.75 |
| Gross Margin | -306.45% |
| Net Profit Margin | -17,158.06% |
| Debt/Equity Ratio | 0% |
How did PRFX perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/09/11 05:23 |
| End of Day Share Price | 2026/09/11 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
PRF Technologies Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jason McCarthy | Maxim Group |
| Nazibur Rahman | Maxim Group |